nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—ABCB1—Methylprednisolone—multiple sclerosis	0.0499	0.102	CbGbCtD
Ketamine—CYP3A4—Fingolimod—multiple sclerosis	0.0464	0.0951	CbGbCtD
Ketamine—CYP2B6—Dexamethasone—multiple sclerosis	0.0368	0.0754	CbGbCtD
Ketamine—ABCB1—Mitoxantrone—multiple sclerosis	0.0364	0.0746	CbGbCtD
Ketamine—ABCB1—Betamethasone—multiple sclerosis	0.0324	0.0665	CbGbCtD
Ketamine—ABCB1—Prednisolone—multiple sclerosis	0.032	0.0656	CbGbCtD
Ketamine—ABCB1—Prednisone—multiple sclerosis	0.0302	0.062	CbGbCtD
Ketamine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0299	0.0613	CbGbCtD
Ketamine—CYP2C8—Dexamethasone—multiple sclerosis	0.0279	0.0571	CbGbCtD
Ketamine—TACR1—trigeminal nerve—multiple sclerosis	0.0235	0.107	CbGeAlD
Ketamine—CYP3A4—Triamcinolone—multiple sclerosis	0.0227	0.0464	CbGbCtD
Ketamine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0218	0.0447	CbGbCtD
Ketamine—CYP2C9—Dexamethasone—multiple sclerosis	0.0194	0.0399	CbGbCtD
Ketamine—CYP3A4—Betamethasone—multiple sclerosis	0.0194	0.0398	CbGbCtD
Ketamine—CYP3A4—Prednisolone—multiple sclerosis	0.0192	0.0393	CbGbCtD
Ketamine—ABCB1—Dexamethasone—multiple sclerosis	0.0189	0.0387	CbGbCtD
Ketamine—CYP3A4—Prednisone—multiple sclerosis	0.0181	0.0371	CbGbCtD
Ketamine—ABCB1—Methotrexate—multiple sclerosis	0.0152	0.0311	CbGbCtD
Ketamine—GRIN2C—nerve—multiple sclerosis	0.0113	0.0516	CbGeAlD
Ketamine—CYP3A4—Dexamethasone—multiple sclerosis	0.0113	0.0232	CbGbCtD
Ketamine—TACR1—peripheral nervous system—multiple sclerosis	0.011	0.0502	CbGeAlD
Ketamine—GRIN2B—nerve—multiple sclerosis	0.00897	0.0408	CbGeAlD
Ketamine—TACR1—nerve—multiple sclerosis	0.0086	0.0391	CbGeAlD
Ketamine—GRIN2A—nerve—multiple sclerosis	0.00784	0.0356	CbGeAlD
Ketamine—Epilepsy—Cladribine—multiple sclerosis	0.00635	0.0831	CcSEcCtD
Ketamine—GRIN2C—brainstem—multiple sclerosis	0.00487	0.0221	CbGeAlD
Ketamine—OPRM1—nerve—multiple sclerosis	0.00476	0.0217	CbGeAlD
Ketamine—GRIN2D—brainstem—multiple sclerosis	0.00453	0.0206	CbGeAlD
Ketamine—GRIN1—brainstem—multiple sclerosis	0.00403	0.0184	CbGeAlD
Ketamine—GRIN2B—brainstem—multiple sclerosis	0.00385	0.0175	CbGeAlD
Ketamine—TACR1—brainstem—multiple sclerosis	0.00369	0.0168	CbGeAlD
Ketamine—SLC6A2—nerve—multiple sclerosis	0.00349	0.0159	CbGeAlD
Ketamine—Obstructive airways disorder—Methotrexate—multiple sclerosis	0.00348	0.0456	CcSEcCtD
Ketamine—GRIN2C—medulla oblongata—multiple sclerosis	0.00339	0.0154	CbGeAlD
Ketamine—GRIN2A—brainstem—multiple sclerosis	0.00336	0.0153	CbGeAlD
Ketamine—DRD2—nerve—multiple sclerosis	0.00318	0.0145	CbGeAlD
Ketamine—GRIN2D—medulla oblongata—multiple sclerosis	0.00316	0.0144	CbGeAlD
Ketamine—Epilepsy—Dexamethasone—multiple sclerosis	0.00286	0.0374	CcSEcCtD
Ketamine—Epilepsy—Betamethasone—multiple sclerosis	0.00286	0.0374	CcSEcCtD
Ketamine—GRIN2D—spinal cord—multiple sclerosis	0.00281	0.0128	CbGeAlD
Ketamine—GRIN1—midbrain—multiple sclerosis	0.00257	0.0117	CbGeAlD
Ketamine—GRIN2C—nervous system—multiple sclerosis	0.00255	0.0116	CbGeAlD
Ketamine—GRIN1—spinal cord—multiple sclerosis	0.00251	0.0114	CbGeAlD
Ketamine—Epilepsy—Prednisone—multiple sclerosis	0.00249	0.0326	CcSEcCtD
Ketamine—GRIN2C—central nervous system—multiple sclerosis	0.00246	0.0112	CbGeAlD
Ketamine—GRIN2C—cerebellum—multiple sclerosis	0.0024	0.0109	CbGeAlD
Ketamine—GRIN2B—spinal cord—multiple sclerosis	0.00239	0.0109	CbGeAlD
Ketamine—GRIN2D—nervous system—multiple sclerosis	0.00237	0.0108	CbGeAlD
Ketamine—GRIN2A—medulla oblongata—multiple sclerosis	0.00235	0.0107	CbGeAlD
Ketamine—TACR1—spinal cord—multiple sclerosis	0.00229	0.0104	CbGeAlD
Ketamine—GRIN2D—central nervous system—multiple sclerosis	0.00228	0.0104	CbGeAlD
Ketamine—GRIN2D—cerebellum—multiple sclerosis	0.00223	0.0102	CbGeAlD
Ketamine—GRIN3A—nervous system—multiple sclerosis	0.00223	0.0101	CbGeAlD
Ketamine—Bradycardia—Fingolimod—multiple sclerosis	0.00218	0.0285	CcSEcCtD
Ketamine—GRIN3A—central nervous system—multiple sclerosis	0.00215	0.00977	CbGeAlD
Ketamine—GRIN2A—midbrain—multiple sclerosis	0.00214	0.00975	CbGeAlD
Ketamine—GRIN1—nervous system—multiple sclerosis	0.00211	0.00962	CbGeAlD
Ketamine—GRIN2A—spinal cord—multiple sclerosis	0.00209	0.00952	CbGeAlD
Ketamine—OPRM1—brainstem—multiple sclerosis	0.00204	0.0093	CbGeAlD
Ketamine—GRIN1—central nervous system—multiple sclerosis	0.00203	0.00926	CbGeAlD
Ketamine—GRIN2B—nervous system—multiple sclerosis	0.00202	0.00917	CbGeAlD
Ketamine—GRIN1—cerebellum—multiple sclerosis	0.00199	0.00905	CbGeAlD
Ketamine—GRIN2C—brain—multiple sclerosis	0.00195	0.00887	CbGeAlD
Ketamine—GRIN2B—central nervous system—multiple sclerosis	0.00194	0.00883	CbGeAlD
Ketamine—TACR1—nervous system—multiple sclerosis	0.00193	0.00879	CbGeAlD
Ketamine—GRIN2B—cerebellum—multiple sclerosis	0.0019	0.00863	CbGeAlD
Ketamine—TACR1—central nervous system—multiple sclerosis	0.00186	0.00847	CbGeAlD
Ketamine—GRIN2D—brain—multiple sclerosis	0.00181	0.00825	CbGeAlD
Ketamine—GRIN2A—nervous system—multiple sclerosis	0.00176	0.00802	CbGeAlD
Ketamine—Vision blurred—Fingolimod—multiple sclerosis	0.00175	0.023	CcSEcCtD
Ketamine—GRIN3A—brain—multiple sclerosis	0.0017	0.00775	CbGeAlD
Ketamine—GRIN2A—central nervous system—multiple sclerosis	0.0017	0.00772	CbGeAlD
Ketamine—GRIN2A—cerebellum—multiple sclerosis	0.00166	0.00755	CbGeAlD
Ketamine—GRIN1—brain—multiple sclerosis	0.00162	0.00735	CbGeAlD
Ketamine—OPRD1—nervous system—multiple sclerosis	0.00157	0.00715	CbGeAlD
Ketamine—GRIN2B—brain—multiple sclerosis	0.00154	0.00701	CbGeAlD
Ketamine—OPRD1—central nervous system—multiple sclerosis	0.00151	0.00688	CbGeAlD
Ketamine—OPRK1—nervous system—multiple sclerosis	0.00151	0.00685	CbGeAlD
Ketamine—SLC6A2—brainstem—multiple sclerosis	0.0015	0.00681	CbGeAlD
Ketamine—TACR1—brain—multiple sclerosis	0.00148	0.00672	CbGeAlD
Ketamine—OPRK1—central nervous system—multiple sclerosis	0.00145	0.0066	CbGeAlD
Ketamine—Hypotension—Fingolimod—multiple sclerosis	0.00142	0.0186	CcSEcCtD
Ketamine—OPRK1—cerebellum—multiple sclerosis	0.00142	0.00645	CbGeAlD
Ketamine—DRD2—brainstem—multiple sclerosis	0.00136	0.00621	CbGeAlD
Ketamine—GRIN2A—brain—multiple sclerosis	0.00135	0.00613	CbGeAlD
Ketamine—DRD2—retina—multiple sclerosis	0.00132	0.00599	CbGeAlD
Ketamine—OPRM1—midbrain—multiple sclerosis	0.0013	0.00593	CbGeAlD
Ketamine—OPRM1—spinal cord—multiple sclerosis	0.00127	0.00578	CbGeAlD
Ketamine—OPRD1—brain—multiple sclerosis	0.0012	0.00546	CbGeAlD
Ketamine—OPRK1—brain—multiple sclerosis	0.00115	0.00524	CbGeAlD
Ketamine—Arrhythmia—Cladribine—multiple sclerosis	0.00108	0.0142	CcSEcCtD
Ketamine—OPRM1—nervous system—multiple sclerosis	0.00107	0.00487	CbGeAlD
Ketamine—Erythema—Cladribine—multiple sclerosis	0.00105	0.0138	CcSEcCtD
Ketamine—SLC6A2—medulla oblongata—multiple sclerosis	0.00104	0.00475	CbGeAlD
Ketamine—OPRM1—central nervous system—multiple sclerosis	0.00103	0.00469	CbGeAlD
Ketamine—Apnoea—Methotrexate—multiple sclerosis	0.000932	0.0122	CcSEcCtD
Ketamine—Arrhythmia—Azathioprine—multiple sclerosis	0.00088	0.0115	CcSEcCtD
Ketamine—DRD2—midbrain—multiple sclerosis	0.00087	0.00396	CbGeAlD
Ketamine—Anorexia—Cladribine—multiple sclerosis	0.00082	0.0107	CcSEcCtD
Ketamine—OPRM1—brain—multiple sclerosis	0.000819	0.00373	CbGeAlD
Ketamine—Bradycardia—Mitoxantrone—multiple sclerosis	0.000811	0.0106	CcSEcCtD
Ketamine—Hypotension—Cladribine—multiple sclerosis	0.000804	0.0105	CcSEcCtD
Ketamine—SLC6A2—nervous system—multiple sclerosis	0.000784	0.00357	CbGeAlD
Ketamine—Cystitis noninfective—Methotrexate—multiple sclerosis	0.000772	0.0101	CcSEcCtD
Ketamine—Cystitis—Methotrexate—multiple sclerosis	0.000763	0.00999	CcSEcCtD
Ketamine—SLC6A2—central nervous system—multiple sclerosis	0.000755	0.00344	CbGeAlD
Ketamine—Decreased appetite—Cladribine—multiple sclerosis	0.000748	0.00979	CcSEcCtD
Ketamine—Pain—Cladribine—multiple sclerosis	0.000736	0.00963	CcSEcCtD
Ketamine—DRD2—nervous system—multiple sclerosis	0.000715	0.00325	CbGeAlD
Ketamine—Bladder pain—Methotrexate—multiple sclerosis	0.000714	0.00935	CcSEcCtD
Ketamine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000711	0.00931	CcSEcCtD
Ketamine—Erythema—Mitoxantrone—multiple sclerosis	0.000693	0.00907	CcSEcCtD
Ketamine—DRD2—central nervous system—multiple sclerosis	0.000688	0.00313	CbGeAlD
Ketamine—DRD2—cerebellum—multiple sclerosis	0.000673	0.00306	CbGeAlD
Ketamine—Bradycardia—Prednisolone—multiple sclerosis	0.000665	0.00871	CcSEcCtD
Ketamine—Hypotension—Azathioprine—multiple sclerosis	0.000654	0.00856	CcSEcCtD
Ketamine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000653	0.00855	CcSEcCtD
Ketamine—PTGS1—spinal cord—multiple sclerosis	0.00062	0.00282	CbGeAlD
Ketamine—Bradycardia—Triamcinolone—multiple sclerosis	0.000612	0.00801	CcSEcCtD
Ketamine—Bradycardia—Methylprednisolone—multiple sclerosis	0.00061	0.00799	CcSEcCtD
Ketamine—Convulsion—Mitoxantrone—multiple sclerosis	0.000601	0.00786	CcSEcCtD
Ketamine—SLC6A2—brain—multiple sclerosis	0.0006	0.00273	CbGeAlD
Ketamine—Arrhythmia—Prednisolone—multiple sclerosis	0.000584	0.00764	CcSEcCtD
Ketamine—CYP2B6—nervous system—multiple sclerosis	0.000578	0.00263	CbGeAlD
Ketamine—ABCB1—retina—multiple sclerosis	0.000569	0.00259	CbGeAlD
Ketamine—Erythema—Prednisolone—multiple sclerosis	0.000569	0.00744	CcSEcCtD
Ketamine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000566	0.00741	CcSEcCtD
Ketamine—Shock—Mitoxantrone—multiple sclerosis	0.000557	0.00729	CcSEcCtD
Ketamine—CYP2B6—central nervous system—multiple sclerosis	0.000557	0.00253	CbGeAlD
Ketamine—Bradycardia—Dexamethasone—multiple sclerosis	0.000555	0.00726	CcSEcCtD
Ketamine—Bradycardia—Betamethasone—multiple sclerosis	0.000555	0.00726	CcSEcCtD
Ketamine—Vomiting—Cladribine—multiple sclerosis	0.000547	0.00716	CcSEcCtD
Ketamine—DRD2—brain—multiple sclerosis	0.000546	0.00249	CbGeAlD
Ketamine—Rash—Cladribine—multiple sclerosis	0.000543	0.0071	CcSEcCtD
Ketamine—Dermatitis—Cladribine—multiple sclerosis	0.000542	0.0071	CcSEcCtD
Ketamine—Anorexia—Mitoxantrone—multiple sclerosis	0.000539	0.00706	CcSEcCtD
Ketamine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000537	0.00703	CcSEcCtD
Ketamine—Vision blurred—Prednisolone—multiple sclerosis	0.000536	0.00702	CcSEcCtD
Ketamine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000536	0.00701	CcSEcCtD
Ketamine—Hypotension—Mitoxantrone—multiple sclerosis	0.000529	0.00692	CcSEcCtD
Ketamine—Erythema—Triamcinolone—multiple sclerosis	0.000523	0.00685	CcSEcCtD
Ketamine—PTGS1—nervous system—multiple sclerosis	0.000523	0.00238	CbGeAlD
Ketamine—Erythema—Methylprednisolone—multiple sclerosis	0.000522	0.00683	CcSEcCtD
Ketamine—Nausea—Cladribine—multiple sclerosis	0.000511	0.00669	CcSEcCtD
Ketamine—PTGS1—central nervous system—multiple sclerosis	0.000503	0.00229	CbGeAlD
Ketamine—Convulsion—Prednisolone—multiple sclerosis	0.000493	0.00645	CcSEcCtD
Ketamine—CYP2C8—brain—multiple sclerosis	0.000493	0.00224	CbGeAlD
Ketamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000492	0.00644	CcSEcCtD
Ketamine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000487	0.00637	CcSEcCtD
Ketamine—Arrhythmia—Betamethasone—multiple sclerosis	0.000487	0.00637	CcSEcCtD
Ketamine—Pain—Mitoxantrone—multiple sclerosis	0.000484	0.00633	CcSEcCtD
Ketamine—Bradycardia—Prednisone—multiple sclerosis	0.000483	0.00633	CcSEcCtD
Ketamine—Erythema—Betamethasone—multiple sclerosis	0.000475	0.00621	CcSEcCtD
Ketamine—Erythema—Dexamethasone—multiple sclerosis	0.000475	0.00621	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000464	0.00608	CcSEcCtD
Ketamine—Shock—Prednisolone—multiple sclerosis	0.000457	0.00598	CcSEcCtD
Ketamine—Convulsion—Triamcinolone—multiple sclerosis	0.000453	0.00593	CcSEcCtD
Ketamine—Convulsion—Methylprednisolone—multiple sclerosis	0.000452	0.00592	CcSEcCtD
Ketamine—Vomiting—Azathioprine—multiple sclerosis	0.000445	0.00582	CcSEcCtD
Ketamine—CYP2B6—brain—multiple sclerosis	0.000442	0.00201	CbGeAlD
Ketamine—Rash—Azathioprine—multiple sclerosis	0.000441	0.00578	CcSEcCtD
Ketamine—Dermatitis—Azathioprine—multiple sclerosis	0.000441	0.00577	CcSEcCtD
Ketamine—CYP3A4—nervous system—multiple sclerosis	0.000436	0.00199	CbGeAlD
Ketamine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000427	0.00559	CcSEcCtD
Ketamine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000426	0.00557	CcSEcCtD
Ketamine—Arrhythmia—Prednisone—multiple sclerosis	0.000424	0.00555	CcSEcCtD
Ketamine—CYP3A4—central nervous system—multiple sclerosis	0.00042	0.00191	CbGeAlD
Ketamine—Shock—Triamcinolone—multiple sclerosis	0.00042	0.0055	CcSEcCtD
Ketamine—Shock—Methylprednisolone—multiple sclerosis	0.000419	0.00548	CcSEcCtD
Ketamine—Nausea—Azathioprine—multiple sclerosis	0.000416	0.00544	CcSEcCtD
Ketamine—Erythema—Prednisone—multiple sclerosis	0.000413	0.00541	CcSEcCtD
Ketamine—ABCB1—medulla oblongata—multiple sclerosis	0.000411	0.00187	CbGeAlD
Ketamine—Convulsion—Dexamethasone—multiple sclerosis	0.000411	0.00538	CcSEcCtD
Ketamine—Convulsion—Betamethasone—multiple sclerosis	0.000411	0.00538	CcSEcCtD
Ketamine—PTGS1—brain—multiple sclerosis	0.000399	0.00182	CbGeAlD
Ketamine—Hypotension—Methylprednisolone—multiple sclerosis	0.000398	0.00521	CcSEcCtD
Ketamine—Pain—Prednisolone—multiple sclerosis	0.000397	0.0052	CcSEcCtD
Ketamine—Vision blurred—Prednisone—multiple sclerosis	0.000389	0.0051	CcSEcCtD
Ketamine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000387	0.00507	CcSEcCtD
Ketamine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000387	0.00507	CcSEcCtD
Ketamine—Shock—Dexamethasone—multiple sclerosis	0.000381	0.00499	CcSEcCtD
Ketamine—Shock—Betamethasone—multiple sclerosis	0.000381	0.00499	CcSEcCtD
Ketamine—ABCB1—midbrain—multiple sclerosis	0.000376	0.00171	CbGeAlD
Ketamine—Anorexia—Betamethasone—multiple sclerosis	0.000369	0.00483	CcSEcCtD
Ketamine—Anorexia—Dexamethasone—multiple sclerosis	0.000369	0.00483	CcSEcCtD
Ketamine—ABCB1—spinal cord—multiple sclerosis	0.000367	0.00167	CbGeAlD
Ketamine—Pain—Triamcinolone—multiple sclerosis	0.000365	0.00478	CcSEcCtD
Ketamine—Hypotension—Dexamethasone—multiple sclerosis	0.000362	0.00474	CcSEcCtD
Ketamine—Hypotension—Betamethasone—multiple sclerosis	0.000362	0.00474	CcSEcCtD
Ketamine—Vomiting—Mitoxantrone—multiple sclerosis	0.00036	0.00471	CcSEcCtD
Ketamine—Convulsion—Prednisone—multiple sclerosis	0.000358	0.00469	CcSEcCtD
Ketamine—Rash—Mitoxantrone—multiple sclerosis	0.000357	0.00467	CcSEcCtD
Ketamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000356	0.00467	CcSEcCtD
Ketamine—Erythema—Methotrexate—multiple sclerosis	0.000345	0.00452	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000337	0.00442	CcSEcCtD
Ketamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000337	0.00441	CcSEcCtD
Ketamine—Decreased appetite—Betamethasone—multiple sclerosis	0.000337	0.00441	CcSEcCtD
Ketamine—Nausea—Mitoxantrone—multiple sclerosis	0.000336	0.0044	CcSEcCtD
Ketamine—Shock—Prednisone—multiple sclerosis	0.000332	0.00434	CcSEcCtD
Ketamine—Pain—Dexamethasone—multiple sclerosis	0.000331	0.00434	CcSEcCtD
Ketamine—Pain—Betamethasone—multiple sclerosis	0.000331	0.00434	CcSEcCtD
Ketamine—Vision blurred—Methotrexate—multiple sclerosis	0.000325	0.00426	CcSEcCtD
Ketamine—Anorexia—Prednisone—multiple sclerosis	0.000321	0.00421	CcSEcCtD
Ketamine—ABCB1—nervous system—multiple sclerosis	0.000309	0.00141	CbGeAlD
Ketamine—Convulsion—Methotrexate—multiple sclerosis	0.000299	0.00392	CcSEcCtD
Ketamine—ABCB1—central nervous system—multiple sclerosis	0.000297	0.00135	CbGeAlD
Ketamine—Decreased appetite—Prednisone—multiple sclerosis	0.000293	0.00384	CcSEcCtD
Ketamine—Rash—Prednisolone—multiple sclerosis	0.000293	0.00383	CcSEcCtD
Ketamine—Dermatitis—Prednisolone—multiple sclerosis	0.000292	0.00383	CcSEcCtD
Ketamine—ABCB1—cerebellum—multiple sclerosis	0.000291	0.00132	CbGeAlD
Ketamine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000282	0.00369	CcSEcCtD
Ketamine—Nausea—Prednisolone—multiple sclerosis	0.000276	0.00361	CcSEcCtD
Ketamine—Vomiting—Triamcinolone—multiple sclerosis	0.000271	0.00355	CcSEcCtD
Ketamine—Vomiting—Methylprednisolone—multiple sclerosis	0.000271	0.00354	CcSEcCtD
Ketamine—Rash—Triamcinolone—multiple sclerosis	0.000269	0.00352	CcSEcCtD
Ketamine—Dermatitis—Triamcinolone—multiple sclerosis	0.000269	0.00352	CcSEcCtD
Ketamine—Anorexia—Methotrexate—multiple sclerosis	0.000269	0.00352	CcSEcCtD
Ketamine—Rash—Methylprednisolone—multiple sclerosis	0.000269	0.00352	CcSEcCtD
Ketamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000268	0.00351	CcSEcCtD
Ketamine—Hypotension—Methotrexate—multiple sclerosis	0.000263	0.00345	CcSEcCtD
Ketamine—Nausea—Triamcinolone—multiple sclerosis	0.000254	0.00332	CcSEcCtD
Ketamine—Nausea—Methylprednisolone—multiple sclerosis	0.000253	0.00331	CcSEcCtD
Ketamine—Vomiting—Betamethasone—multiple sclerosis	0.000246	0.00322	CcSEcCtD
Ketamine—Vomiting—Dexamethasone—multiple sclerosis	0.000246	0.00322	CcSEcCtD
Ketamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000245	0.00321	CcSEcCtD
Ketamine—Rash—Betamethasone—multiple sclerosis	0.000244	0.0032	CcSEcCtD
Ketamine—Rash—Dexamethasone—multiple sclerosis	0.000244	0.0032	CcSEcCtD
Ketamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000244	0.00319	CcSEcCtD
Ketamine—Dermatitis—Betamethasone—multiple sclerosis	0.000244	0.00319	CcSEcCtD
Ketamine—Pain—Methotrexate—multiple sclerosis	0.000241	0.00316	CcSEcCtD
Ketamine—ABCB1—brain—multiple sclerosis	0.000236	0.00107	CbGeAlD
Ketamine—Nausea—Dexamethasone—multiple sclerosis	0.00023	0.00301	CcSEcCtD
Ketamine—Nausea—Betamethasone—multiple sclerosis	0.00023	0.00301	CcSEcCtD
Ketamine—Vomiting—Prednisone—multiple sclerosis	0.000214	0.00281	CcSEcCtD
Ketamine—Rash—Prednisone—multiple sclerosis	0.000213	0.00278	CcSEcCtD
Ketamine—Dermatitis—Prednisone—multiple sclerosis	0.000212	0.00278	CcSEcCtD
Ketamine—Nausea—Prednisone—multiple sclerosis	0.0002	0.00262	CcSEcCtD
Ketamine—Vomiting—Methotrexate—multiple sclerosis	0.000179	0.00235	CcSEcCtD
Ketamine—Rash—Methotrexate—multiple sclerosis	0.000178	0.00233	CcSEcCtD
Ketamine—Dermatitis—Methotrexate—multiple sclerosis	0.000178	0.00232	CcSEcCtD
Ketamine—Nausea—Methotrexate—multiple sclerosis	0.000167	0.00219	CcSEcCtD
Ketamine—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	4.86e-05	0.000225	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCR3—multiple sclerosis	4.79e-05	0.000222	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	4.79e-05	0.000222	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TGFB1—multiple sclerosis	4.76e-05	0.00022	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.76e-05	0.00022	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.76e-05	0.00022	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	4.74e-05	0.00022	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	4.73e-05	0.000219	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	4.69e-05	0.000217	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL3—multiple sclerosis	4.68e-05	0.000217	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MAPK1—multiple sclerosis	4.67e-05	0.000216	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PGR—multiple sclerosis	4.67e-05	0.000216	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CCR2—multiple sclerosis	4.66e-05	0.000216	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.65e-05	0.000215	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	4.64e-05	0.000215	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TGFB1—multiple sclerosis	4.64e-05	0.000215	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—APOE—multiple sclerosis	4.63e-05	0.000215	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	4.62e-05	0.000214	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	4.58e-05	0.000212	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MAPK1—multiple sclerosis	4.55e-05	0.000211	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CD28—multiple sclerosis	4.53e-05	0.00021	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PTGER4—multiple sclerosis	4.5e-05	0.000209	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RGS1—multiple sclerosis	4.47e-05	0.000207	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	4.45e-05	0.000206	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TNF—multiple sclerosis	4.44e-05	0.000206	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	4.4e-05	0.000204	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCR3—multiple sclerosis	4.35e-05	0.000202	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.35e-05	0.000202	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TNF—multiple sclerosis	4.33e-05	0.000201	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.33e-05	0.000201	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	4.32e-05	0.0002	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CNR1—multiple sclerosis	4.3e-05	0.000199	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	4.26e-05	0.000197	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—RRM1—multiple sclerosis	4.26e-05	0.000197	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GPR65—multiple sclerosis	4.24e-05	0.000197	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	4.23e-05	0.000196	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	4.2e-05	0.000194	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CD80—multiple sclerosis	4.19e-05	0.000194	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	4.18e-05	0.000194	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	4.15e-05	0.000193	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—POMC—multiple sclerosis	4.15e-05	0.000192	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.14e-05	0.000192	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.14e-05	0.000192	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.12e-05	0.000191	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	4.11e-05	0.00019	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PGR—multiple sclerosis	4.09e-05	0.00019	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	4.06e-05	0.000188	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	4.01e-05	0.000186	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	3.99e-05	0.000185	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—POMC—multiple sclerosis	3.98e-05	0.000184	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CD28—multiple sclerosis	3.98e-05	0.000184	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	3.96e-05	0.000184	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	3.91e-05	0.000181	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.91e-05	0.000181	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	3.9e-05	0.000181	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCL2—multiple sclerosis	3.89e-05	0.00018	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	3.88e-05	0.00018	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR1—multiple sclerosis	3.88e-05	0.00018	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.87e-05	0.000179	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.87e-05	0.000179	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.87e-05	0.000179	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—MAPK1—multiple sclerosis	3.81e-05	0.000177	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	3.8e-05	0.000176	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GPC5—multiple sclerosis	3.79e-05	0.000176	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.78e-05	0.000175	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.72e-05	0.000172	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	3.71e-05	0.000172	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	3.7e-05	0.000171	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	3.66e-05	0.00017	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	3.65e-05	0.000169	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SRM—multiple sclerosis	3.62e-05	0.000168	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.6e-05	0.000167	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	3.6e-05	0.000167	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	3.6e-05	0.000167	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—IL6—multiple sclerosis	3.59e-05	0.000166	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	3.55e-05	0.000164	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.54e-05	0.000164	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TYK2—multiple sclerosis	3.54e-05	0.000164	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	3.52e-05	0.000163	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	3.51e-05	0.000163	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—IL6—multiple sclerosis	3.5e-05	0.000162	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PGR—multiple sclerosis	3.46e-05	0.00016	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	3.39e-05	0.000157	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.39e-05	0.000157	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	3.38e-05	0.000157	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	3.37e-05	0.000156	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CD28—multiple sclerosis	3.36e-05	0.000156	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.36e-05	0.000156	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	3.33e-05	0.000154	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	3.33e-05	0.000154	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	3.3e-05	0.000153	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	3.26e-05	0.000151	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	3.24e-05	0.00015	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CD86—multiple sclerosis	3.23e-05	0.00015	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—BCHE—multiple sclerosis	3.21e-05	0.000149	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	3.18e-05	0.000148	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—RRM1—multiple sclerosis	3.14e-05	0.000146	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	3.1e-05	0.000144	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	3.09e-05	0.000143	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	3.04e-05	0.000141	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	3.03e-05	0.00014	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	3e-05	0.000139	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.96e-05	0.000137	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	2.96e-05	0.000137	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	2.95e-05	0.000137	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL2—multiple sclerosis	2.94e-05	0.000136	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.93e-05	0.000136	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL6—multiple sclerosis	2.93e-05	0.000136	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.9e-05	0.000134	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.89e-05	0.000134	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	2.87e-05	0.000133	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CD86—multiple sclerosis	2.84e-05	0.000131	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.83e-05	0.000131	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	2.83e-05	0.000131	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	2.81e-05	0.00013	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	2.81e-05	0.00013	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.8e-05	0.00013	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	2.79e-05	0.000129	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MMP9—multiple sclerosis	2.79e-05	0.000129	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL3—multiple sclerosis	2.76e-05	0.000128	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	2.75e-05	0.000128	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	2.74e-05	0.000127	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	2.73e-05	0.000126	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	2.71e-05	0.000126	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.7e-05	0.000125	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	2.69e-05	0.000125	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	2.66e-05	0.000123	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PGR—multiple sclerosis	2.62e-05	0.000121	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—APOE—multiple sclerosis	2.61e-05	0.000121	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	2.59e-05	0.00012	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	2.57e-05	0.000119	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.55e-05	0.000118	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.55e-05	0.000118	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD28—multiple sclerosis	2.55e-05	0.000118	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	2.52e-05	0.000117	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR2—multiple sclerosis	2.5e-05	0.000116	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	2.5e-05	0.000116	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	2.48e-05	0.000115	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—STAT3—multiple sclerosis	2.48e-05	0.000115	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	2.46e-05	0.000114	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.45e-05	0.000113	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.4e-05	0.000111	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CD86—multiple sclerosis	2.4e-05	0.000111	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	2.36e-05	0.000109	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CD80—multiple sclerosis	2.36e-05	0.000109	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	2.35e-05	0.000109	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.34e-05	0.000108	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	2.31e-05	0.000107	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MYC—multiple sclerosis	2.3e-05	0.000107	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TGFB1—multiple sclerosis	2.3e-05	0.000106	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	2.29e-05	0.000106	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APOE—multiple sclerosis	2.29e-05	0.000106	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.28e-05	0.000105	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MAPK1—multiple sclerosis	2.25e-05	0.000104	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—POMC—multiple sclerosis	2.24e-05	0.000104	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	2.19e-05	0.000102	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.19e-05	0.000101	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	2.19e-05	0.000101	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	2.15e-05	9.94e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	2.13e-05	9.88e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	2.13e-05	9.85e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	2.1e-05	9.71e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	2.09e-05	9.66e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	2.08e-05	9.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	2.08e-05	9.63e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.07e-05	9.59e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CD80—multiple sclerosis	2.07e-05	9.59e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	1.99e-05	9.23e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—POMC—multiple sclerosis	1.97e-05	9.11e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.96e-05	9.06e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.93e-05	8.96e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APOE—multiple sclerosis	1.93e-05	8.96e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—APOE—multiple sclerosis	1.93e-05	8.93e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	1.92e-05	8.91e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	1.89e-05	8.77e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	1.88e-05	8.72e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.82e-05	8.42e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.81e-05	8.41e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.8e-05	8.36e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.79e-05	8.29e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.78e-05	8.26e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CD80—multiple sclerosis	1.75e-05	8.1e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	1.75e-05	8.09e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.74e-05	8.04e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—multiple sclerosis	1.73e-05	8.01e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.69e-05	7.81e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—POMC—multiple sclerosis	1.66e-05	7.7e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—multiple sclerosis	1.66e-05	7.68e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—POMC—multiple sclerosis	1.66e-05	7.68e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.66e-05	7.67e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	1.65e-05	7.64e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	1.63e-05	7.53e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.61e-05	7.46e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.59e-05	7.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.59e-05	7.36e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.58e-05	7.3e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	1.57e-05	7.27e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—multiple sclerosis	1.51e-05	7e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	1.48e-05	6.84e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.47e-05	6.82e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.47e-05	6.79e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—multiple sclerosis	1.45e-05	6.73e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	1.45e-05	6.7e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	1.39e-05	6.46e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	1.38e-05	6.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.33e-05	6.14e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—multiple sclerosis	1.3e-05	6e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	1.29e-05	5.99e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	1.27e-05	5.87e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.26e-05	5.86e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.26e-05	5.83e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOE—multiple sclerosis	1.25e-05	5.77e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.23e-05	5.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—multiple sclerosis	1.23e-05	5.69e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	1.22e-05	5.67e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	1.22e-05	5.66e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.21e-05	5.59e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	1.16e-05	5.39e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—multiple sclerosis	1.15e-05	5.34e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—multiple sclerosis	1.14e-05	5.27e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	1.13e-05	5.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.12e-05	5.18e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	1.11e-05	5.15e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.11e-05	5.15e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOE—multiple sclerosis	1.09e-05	5.03e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—POMC—multiple sclerosis	1.07e-05	4.96e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	1.03e-05	4.79e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOE—multiple sclerosis	1.01e-05	4.7e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—multiple sclerosis	9.75e-06	4.52e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—multiple sclerosis	9.74e-06	4.51e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—multiple sclerosis	9.6e-06	4.45e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	9.58e-06	4.44e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	9.4e-06	4.35e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—POMC—multiple sclerosis	9.32e-06	4.32e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—multiple sclerosis	9.31e-06	4.31e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	9.26e-06	4.29e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	8.81e-06	4.08e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—POMC—multiple sclerosis	8.71e-06	4.03e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—multiple sclerosis	8.54e-06	3.96e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—multiple sclerosis	8.5e-06	3.94e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—multiple sclerosis	7.94e-06	3.68e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	7.83e-06	3.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—multiple sclerosis	7.28e-06	3.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	7.26e-06	3.36e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—multiple sclerosis	7.22e-06	3.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	7.12e-06	3.3e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOE—multiple sclerosis	6.69e-06	3.1e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—POMC—multiple sclerosis	5.74e-06	2.66e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—multiple sclerosis	5.47e-06	2.54e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—multiple sclerosis	5.24e-06	2.43e-05	CbGpPWpGaD
